Grants and Contributions:
Title:
Emagix Software System Development
Agreement Number:
918169
Agreement Value:
$128,445.00
Agreement Date:
Dec 17, 2018 - Nov 30, 2019
Description:
Emagix’s prototype fluorescein angiography software analyses a series of images of the retina to assess the permeability of retinal blood vessels associated with diabetic retinopathy. The objective of this project is to transpose the software from a prototype Matlab environment into a production platform, with commercially viable performance goals.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Halifax, Nova Scotia, CA B3H 0A8
Reference Number:
172-2018-2019-Q4-918169
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
788528321
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 91 days.
Amendment Date
Jul 30, 2019
Recipient's Legal Name:
Emagix Inc.
Federal Riding Name:
Halifax
Federal Riding Number:
12005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211
Amendments: